Loading...
A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
BACKGROUND/AIMS: Metronomic chemotherapy (MET) is frequently administered in comparatively low doses as a continuous chemotherapeutic agent. The aim of this study was to evaluate the feasibility and overall survival (OS) of MET compared to sorafenib for advanced hepatocellular carcinoma (HCC) patien...
Na minha lista:
| Udgivet i: | Clin Mol Hepatol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Korean Association for the Study of the Liver
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5497665/ https://ncbi.nlm.nih.gov/pubmed/28494528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0071 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|